ASCO is pleased to welcome the 2020–2021 Board of Directors and introduce the newly installed leaders who began their terms at the conclusion of the Annual Business Meeting on June 1, 2020.
ASCO and the Board of Directors extend their sincere gratitude to the outgoing Board members whose terms concluded in 2020, and to the members who serve on and lead committees, working groups, task forces, editorial boards, councils, expert panels, and other groups. The success of ASCO and Conquer Cancer, the ASCO Foundation, would not be possible without the time, talent, expertise, and creativity of these generous and dedicated volunteers.
OFFICERS
Chair of the Board
Howard A. “Skip” Burris III, MD, FACP, FASCO, Sarah Cannon Research Institute
President
Lori J. Pierce, MD, FASTRO, FASCO , University of Michigan
President-Elect
Everett E. Vokes, MD, FASCO, University of Chicago Medicine and Biological Sciences
Past President
Monica M. Bertagnolli, MD, FACS, FASCO, Brigham and Women’s Hospital and Dana-Farber Cancer Institute
Treasurer
Laurie E. Gaspar, MD, MBA, FASTRO, FACR, FASCO, Banner MD Anderson Cancer Center at North Colorado Medical Center and University of Colorado
DIRECTORS
Undesignated Specialty
Ethan M. Basch, MD, MSc, FASCO, University of North -Carolina Lineberger Comprehensive Cancer Center
Radiation Oncologist
A. William Blackstock, MD, FASCO , Wake Forest University School of Medicine
Undesignated Specialty
Lisa A. Carey, MD, FASCO, University of North Carolina Lineberger Comprehensive Cancer Center
Undesignated Specialty
Lee M. Ellis, MD, FACS, FASCO, The University of Texas MD Anderson Cancer Center
Pediatric Oncologist
Tara O. Henderson, MD, MPH, FASCO, University of Chicago Comprehensive Cancer Center
Undesignated Specialty
Reshma Jagsi, MD, DPhil, FASTRO, FASCO, University of Michigan Medicine
Community Oncologist
Michael P. Kosty, MD, FACP, FASCO, Scripps Green Cancer Center
Surgical Oncologist
Elizabeth A. Mittendorf, MD, PhD, Brigham and Women’s Hospital and Dana-Farber Cancer Institute
International Oncologist
Tony S. K. Mok, BMSc, MD, FRCP(C), FRCP (Edin.), FHKCP, FHKAM (Medicine), FASCO, The Chinese University of Hong Kong
Undesignated Specialty
Elizabeth R. Plimack, MD, MS, Fox Chase Cancer Center
Medical Oncologist
Eric J. Small, MD, FASCO, University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center
International Oncologist
Enrique Soto Pérez de Celis, MD, MSc , Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
Community Oncologist
Michael A. Thompson, MD, PhD, FASCO, Advocate Aurora Health
Community Oncologist
Tracey F. Weisberg, MD, FASCO, New England Cancer Specialists
EX-OFFICIO MEMBERS
Chair, Conquer Cancer Board
Thomas G. Roberts, Jr., MD, FASCO, Farallon Capital Management, LLC
CHIEF EXECUTIVE OFFICER
Clifford A. Hudis, MD, FACP, FASCO, ASCO
© 2020. American Society of Clinical Oncology. All rights reserved.
